Recent Company News

• 09:21 AM ET May 11, 2026
  

  StreetAccount Summary - US Pre-market trading update

• 08:49 AM ET May 11, 2026
  

  StreetAccount Sector Summary - Healthcare Pre-Market

• 08:23 AM ET May 07, 2026
  

  StreetAccount Summary - US Pre-market trading

• 07:02 AM ET May 11, 2026
  

  Zai Lab receives U.S. FDA Fast Track designation for Zocilurtatug Pelitecan (Zoci) ($18.60, 0.00)

• 05:27 PM ET May 08, 2026
  

  argenx announces US FDA approval expanding VYVGART and VYVGART Hytrulo for use in all adult patients living with generalized myasthenia gravis ($782.17, 0.00)

• 11:55 AM ET May 07, 2026
  

  Transcript Intelligence: ZAI Lab Q1 Earnings Guidance ($19.50, -1.51)

• 11:54 AM ET May 07, 2026
  

  Transcript Intelligence: ZAI Lab Q1 Earnings Q&A ($19.39, -1.62)

• 11:54 AM ET May 07, 2026
  

  Transcript Intelligence: ZAI Lab Q1 Earnings Themes ($19.38, -1.63)

• 06:10 AM ET May 07, 2026
  

  StreetAccount Metrics Recap - ZAI Lab Q1 Earnings ($21.01, 0.00)